Podcasts about bicar icu

Marcela e Lucas discutem como quando repor bicarbonato, como repor e os efeitos adversos da reposição. Referências. Samir Jaber, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. The Lancet - Published:June 14, 2018DOI:https://doi.org/10.1016/S0140-6736(18)31080-8 Michael Emmett, et al. Approach to the adult with metabolic acidosis. UpToDate 2023 Josh Farkas - PulmCrit: pH-guided fluid resuscitation & BICAR-ICU - 2018 Michael Wiederkehr, et al. Bicarbonate therapy in lactic acidosis. UpToDate 2023

Join us on this podcast as we discuss Renal Replacement Therapy with Professor Sean Bagshaw from the University of Alberta Hospital, Edmonton, Canada. Dr. Bagshaw is Professor and Chair for the Department of Critical Care Medicine at the University of Alberta in Edmonton, Canada. He completed medical school and residency training at the University of Calgary (Doctor of Medicine – 2000; Internal Medicine – 2003; Critical Care Medicine – 2005; Master of Science in Epidemiology – 2005) prior to completing a Critical Care Nephrology fellowship in the Department of Intensive Care Medicine, at the Austin Hospital in Melbourne, Australia. Dr. Bagshaw works as a full-time staff intensivist in two of the busiest and highest acuity intensive care units in Alberta – the General Systems ICU at the University of Alberta Hospital and the Cardiovascular Surgical ICU at the Mazankowski Alberta Health Institute. Dr. Bagshaw has expertise in acute kidney injury, renal replacement therapy, frailty and vulnerable patients and end-of-life care in ICU settings. He has published over 400 peer-reviewed articles and it was our absolute privilege to have him on the show. In this episode we talk about timing of replacement therapy, data around continuous and intermittent therapy, intensity of dialysis, fluid management, anticoagulation and weaning of renal replacement therapy. Articles of Interest: 1. Timing of Initiation of  Renal-Replacement Therapy in Acute Kidney Injury. New England Journal of  Medicine. 2020 Jul 16;383(3):240–51. 2. Zarbock A, Kellum JA, Schmidt C, van  Aken H, Wempe C, Pavenstädt H, et al. Effect of Early vs Delayed Initiation of  Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute  Kidney Injury. JAMA. 2016 May 24;315(20):2190. 3. Barbar SD, Clere-Jehl R, Bourredjem A,  Hernu R, Montini F, Bruyère R, et al. Timing of Renal-Replacement Therapy in  Patients with Acute Kidney Injury and Sepsis. New England Journal of Medicine.  2018 Oct 11;379(15):1431–42. 4. Gaudry S, Hajage D, Schortgen F,  Martin-Lefevre L, Pons B, Boulet E, et al. Initiation Strategies for  Renal-Replacement Therapy in the Intensive Care Unit. New England Journal of  Medicine. 2016 Jul 14;375(2):122–33. 5. Jaber S, Paugam C, Futier E, Lefrant  JY, Lasocki S, Lescot T, et al. Sodium bicarbonate therapy for patients with  severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a  multicentre, open-label, randomised controlled, phase 3 trial. The Lancet.  2018 Jul;392(10141):31–40. 6. Intensity of Continuous  Renal-Replacement Therapy in Critically Ill Patients. New England Journal of  Medicine. 2009 Oct 22;361(17):1627–38. 7. Intensity of Renal Support in  Critically Ill Patients with Acute Kidney Injury. New England Journal of  Medicine. 2008 Jul 3;359(1):7–20.

Have you ever wondered why we don't give sodium bicarbonate to patients with a metabolic acidosis or a lactic acidosis? In this podcast I discuss the historical context of it and bring forth more recent data that may change the mind of the naysayers. Show Notes: https://eddyjoemd.com/lactic-acid-sepsis Receive a FREE audiobook (TWO for Amazon Prime members) with your FREE 30-day trial by using my link for Audible: CLICK HERE! You will be reminded when your trial is ending, by the way.

Bicarbonato na acidose é bom para o paciente ou só para a gasometria? Nesse podcast a Dra. Elen da Mata, convidada da semana, explica os riscos, possíveis benefícios e doses de bicarbonato venoso a serem utilizados em pacientes com acidose metabólica, avaliando principalmente os resultados do estudo BICAR-ICU, publicado na Revista LANCET.

Le Professeur Roux, PUPH en médecine intensive et réanimation à l’Hôpital Louis Mourier à Colombes, nous parle de l’acidose métabolique.Aucun lien d’intérêt déclaré.Sommaire :• Comment fait-on le diagnostic ?• Quelle prise en charge thérapeutique ?• Quels sont les pièges à éviter ?Références :• Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial.Jaber et al.Lancet. 2018 Jul 7;392(10141):31-40. DOI : 10.1016/S0140-6736(18)31080-8• Management of life-threatening acid-base disorders. First of two parts.Adrogué HJ1, Madias NE.N Engl J Med. 1998 Jan 1;338(1):26-34. DOI: 10.1056/NEJM199801013380106• Diagnostic et Prise en Charge de l’Acidose Métabolique.Jung et al.Diving and Hyperbaric Medicine. 2017 March;47(1):24-32. Méd. Intensive Réa (2019) 28:481-502.

Die Gabe von Natrium-Bikarbonat bei der akuten metabolischen Azidose ist ein immer wieder heiß diskutiertes Thema. Die BICAR-ICU-Studie trägt wichtige prospektive Daten dazu bei - wir haben sie für euch "zusammengereimt" und diskutiert.

Torsdag den 2. maj blev der afholdt Copenhagen Critical Care symposium. Vi deltog, bla. med en podcast hvor vi tog en snak med næsten alle talerne. Her får du deres 3-4 take homes points fra netop deres tale. Vi snakker om ledelse, opbygning af kultur, brandsårsbehandling og meget mere. Hør podcasten hvor de nyeste anbefalinger om brandsårsbehandling gennemgås, behandling for Rhabdomyolyse analyseres. Akronymet MONA aflives af Kardiolog Jens Rosenberg. En fantastisk session om lederskab og meget mere. Se tiderne for de forskellige emner her under 02:00 Lederskab med Thomas Bøllingtoft Knudsen,Randi Beier & Ture Larsen, Roger Harris14:50 Massetilskadekomst med Christina Hernon (US), Dan Lou Isbye og Kristian Andersen29:50 Critical care er ikke ét speciale med Monika Afzali Rubin og Karl Høeg40:15 Toxikologi - Christina Hernon (US), 45:21 Brandsår - Rikke Holmgaard, Christian Overgaard Steensen & Martin Risom Vestergaard51:50 Mythbusters - Jens Rosenberg, Jens Michelsen, Thomas Bøllingtoft Knudsen01:01:11 Critical Care litteratur update 2019 - Thomas Strøm ogLars Simon Rasmussen Abonner eller hent via iTunes for iOS og for android via Podbean. Nu også via TUNE IN Se vores egen Karl Høeg som vært på FOAMmedic Talk hvor han interviewer Læge Monika Afzali Rubin https://www.youtube.com/watch?v=WnrmbQCqPTg Links og referencer: Se hele cphcc2019 på vores søster blog scanFOAM https://www.youtube.com/watch?v=WLYujtTXfLQ Paper battle mellem Thomas Strøm og Lars S. Rasmussen, her er de fire artikler som blev debatteret, hør vores snak ved 01:01:11 i podcasten: Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.Barbar SD, Dargent A, Quenot JP. N Engl J Med. 2019 Jan 24;380(4):399. Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults. Casey JD, Janz DR, Russell DW, Vonderhaar DJ, Joffe AM, Dischert KM, Brown RM, Zouk AN, Gulati S, Heideman BE, Lester MG, Toporek AH, Bentov I, Self WH, Rice TW, Semler MW; PreVent Investigators and the Pragmatic Critical Care Research Group. N Engl J Med. 2019 Feb 28;380(9):811-821 Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence Induction of Anesthesia: The IRIS Randomized Clinical Trial. Birenbaum A, Hajage D, Roche S, Ntouba A, Eurin M, Cuvillon P, Rohn A, Compere V, Benhamou D, Biais M, Menut R, Benachi S, Lenfant F, Riou B; IRIS Investigators Group. JAMA Surg. 2019 Jan 1;154(1):9-17 Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Jaber S, Paugam C, Futier E, Lefrant JY, Lasocki S, Lescot T, Pottecher J, Demoule A, Ferrandière M, Asehnoune K, Dellamonica J, Velly L, Abback PS, de Jong A, Brunot V, Belafia F, Roquilly A, Chanques G, Muller L, Constantin JM, Bertet H, Klouche K, Molinari N, Jung B; BICAR-ICU Study Group. Lancet. 2018 Jul 7;392(10141):31-40 Støt FOAMmedics arbejde med 5 eller 10 kr pr. podcast. Hvis du har lyst til at støtte vores arbejde med at lave lækker lyd og skrift så klik ind på 10er.dk og støt os med 5, 10 eller 15 pr. podcast episode, så bliver vi så sindsygt stolte og glade. Eller klik på 10'er logo her under og en pop-up løsning kommer frem.

Le Professeur Samir Jaber nous parle de l'étude BICAR-ICU, publiée dans le Lancet en juin 2018, portant sur l'utilisation du bicarbonate de sodium dans le traitement des acidoses métaboliques sévères. Article en lien:Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial (doi 10.1016/S0140-6736(18)31080-8)

In this episode, episode 98, I discuss the BICAR-ICU trial and what it tells us about using sodium bicarbonate to treat metabolic acidosis. References: BICAR-ICU Trial: https://www.ncbi.nlm.nih.gov/pubmed/29910040 BICAR-ICU Editorial: https://www.ncbi.nlm.nih.gov/pubmed/29910039 Forsythe: https://www.ncbi.nlm.nih.gov/pubmed/10631227 Sabatini: https://www.ncbi.nlm.nih.gov/pubmed/18322160 Pulmcrit post: https://emcrit.org/pulmcrit/bicar-icu/  

Bicar-ICU changes my practice with bicarb infusions and let's end the great lactate debate on EMCrit 227: